BioPharma
-
BrightInsight CEO Kal Patel M.D. discusses the future of regulated digital health for biopharma and medtech
In order to benefit from the Virtual1Care trend, pharma and medtech companies must ensure that their digital health tools, wrapped around a drug or device, comply with evolving regulations.
-
Remote service: The new paradigm for biopharma manufacturing
Microsoft seeks to change the way pharma industry companies use technology to navigate human resource challenges and restore confidence in drug development supply chains.
-
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
-
BioT webinar will explore personalized approach to connected care
The webinar on November 18th at 1pm ETwill address considerations around building a personalized connected care solution and how you can achieve it in a very short timeframe.
-
StartUPDATES: New developments from healthcare startups
Check out news from Healthmine, Marley Medical, Alloy, Culture Biosciences and more.
-
Navigating the life science and healthcare funding landscape
Which capital funding options fit your healthcare or life science business?
-
Astellas Pharma reports fourth patient death in gene therapy clinical trial
The death occurred less than two weeks after Astellas Pharma reported that the patient developed liver problems after being dosed with the experimental gene therapy for a rare neuromuscular disorder. Astellas said the cause of death is still under investigation, and the FDA has placed a clinical hold on the study.
-
Emulate CEO shares the organ-chip maker’s vision to understand and predict drug response
Each Organ-Chip is a transparent, flexible microenvironment that contains two parallel chambers that can be configured to grow human cells from an organ of interest, such as the liver, kidney proximal tubule, intestine, lung and brain
-
CG Oncology CEO highlights biotech’s oncolytic immunotherapy for bladder cancer
CG Oncology CEO Arthur Kuan talked about the biotech company’s experimental bladder cancer treatment in Phase 3 development and collaboration with Merck, among the company’s milestones, in response to emailed questions.
-
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
-
Day 2 of INVEST Precision Medicine: Life science startup pitches, biopharma software R&D, and more
Register for INVEST Precision Medicine to check out the life science track of the Pitch Perfect startup contest and hear compelling panel discussions on software supporting biopharma R&D, and the supply chain challenges of scaling production and delivering personalized therapies.
-
StartUPDATES: New developments from healthcare startups
Read about news from life science companies Emulate, Astrocyte Pharmaceuticals and Bone Health Technologies.
-
The winners of INVEST Pitch Perfect are…..
The finalists across health IT, biopharma, medical devices, diagnostics, and health services tracks were judged on criteria that included: completeness of overall plan, business idea, market opportunity, revenue model, and founder(s) experience.
-
Cellino Biotech developing tech to help scale stem cell therapies
Cellino Biotech CEO and Co-founder Dr. Nabiha Saklayen talked about the formation of the company and its goal to make stem cell therapies accessible for patients.
-
3 changes coming to drug pricing
No matter if Democrats or Republicans are running the show in Washington, here are three solid bets for pharma companies to plan for in the changing drug-pricing landscape
-
J.P. Morgan’s life sciences outlook for 2021
Peter Meath, J.P. Morgan Commercial Banking’s Co-Head of Healthcare and Life Sciences, applies lessons from 2020’s remarkable second half and shares insights on what to expect in 2021.